Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Study of LY3009104 in Healthy Volunteers
A Placebo-Controlled, Single Dose, Dose Escalation (Part A) and a Placebo- and Positive-Controlled Study of the Effect on the Electrocardiographic QT Interval of a Single Dose (Part B) of LY3009104 in Healthy Subjects
Status: Enrolling
Updated:  11/1/2012
Clinical Research Facility
mi
from
Miami, FL
A Study of LY3009104 in Healthy Volunteers
A Placebo-Controlled, Single Dose, Dose Escalation (Part A) and a Placebo- and Positive-Controlled Study of the Effect on the Electrocardiographic QT Interval of a Single Dose (Part B) of LY3009104 in Healthy Subjects
Status: Enrolling
Updated: 11/1/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
A Phase 1, Open-label, Single-dose, Randomized, 4-treatment, 4- Period, Crossover, Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene (Bza) Compared With A Reference Tablet Formulation of Bza/Conjugated Estrogens (ce) in Healthy Postmenopausal Women
Status: Enrolling
Updated:  11/5/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
A Phase 1, Open-label, Single-dose, Randomized, 4-treatment, 4- Period, Crossover, Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene (Bza) Compared With A Reference Tablet Formulation of Bza/Conjugated Estrogens (ce) in Healthy Postmenopausal Women
Status: Enrolling
Updated: 11/5/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Status: Enrolling
Updated:  11/6/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Role of Endogenous Estrogen in Growth-Hormone Regulation in Postmenopausal Women
Status: Enrolling
Updated: 11/6/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Effect of Metabolic State on Anxiety in Human Subjects
Effect of Metabolic State on Anxiety in Human Subjects
Status: Enrolling
Updated:  11/7/2012
Rockefeller University
mi
from
New York, NY
Effect of Metabolic State on Anxiety in Human Subjects
Effect of Metabolic State on Anxiety in Human Subjects
Status: Enrolling
Updated: 11/7/2012
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials
Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation
An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Ethanol 20% and 40% on the Bioavailability a Controlled Release Formulation of Oxycodone 20 Mg With Sequestered Naltrexone 2.4 Mg in Healthy Volunteers
Status: Enrolling
Updated:  11/12/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation
An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Ethanol 20% and 40% on the Bioavailability a Controlled Release Formulation of Oxycodone 20 Mg With Sequestered Naltrexone 2.4 Mg in Healthy Volunteers
Status: Enrolling
Updated: 11/12/2012
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Lutein Absorption in Healthy Adults
Lutein Absorption in Healthy Adults
Status: Enrolling
Updated:  11/16/2012
Biofortis Clinical Research
mi
from
Addison, IL
Lutein Absorption in Healthy Adults
Lutein Absorption in Healthy Adults
Status: Enrolling
Updated: 11/16/2012
Biofortis Clinical Research
mi
from
Addison, IL
Click here to add this to my saved trials
Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits
Influence of Medication Palatability on Prescribing Habits of Pediatric Prescribers
Status: Enrolling
Updated:  11/21/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits
Influence of Medication Palatability on Prescribing Habits of Pediatric Prescribers
Status: Enrolling
Updated: 11/21/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy
Developing Anesthesia as PTSD Therapy
Status: Enrolling
Updated:  11/27/2012
University of California, Irvine
mi
from
Irvine, CA
Developing Anesthesia as Post Traumatic Stress Disorder (PTSD) Therapy
Developing Anesthesia as PTSD Therapy
Status: Enrolling
Updated: 11/27/2012
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Brain Imaging Study of F17464
Status: Enrolling
Updated:  12/5/2012
Clinical Research Facility
mi
from
New York, NY
Brain Imaging Study of F17464
Status: Enrolling
Updated: 12/5/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers
Status: Enrolling
Updated:  12/20/2012
Clinical Pharmacology of Miami
mi
from
Miami, FL
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers
Status: Enrolling
Updated: 12/20/2012
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers in Cleveland
Status: Enrolling
Updated:  12/26/2012
MomsFirst
mi
from
Cleveland, OH
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers in Cleveland
Status: Enrolling
Updated: 12/26/2012
MomsFirst
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants
A Double-Blind, Randomized, Placebo-Controlled, Sequential Group, Single Ascending and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Subjects
Status: Enrolling
Updated:  1/2/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants
A Double-Blind, Randomized, Placebo-Controlled, Sequential Group, Single Ascending and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Subjects
Status: Enrolling
Updated: 1/2/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Miami, FL
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Orlando, FL
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Neptune, NJ
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Parallel Group Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of Pf-04895162 In Healthy Subjects
Status: Enrolling
Updated:  1/7/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
A Double Blind (3rd Party Open) Randomized, Placebo Controlled, Parallel Group Dose Escalation Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of Pf-04895162 In Healthy Subjects
Status: Enrolling
Updated: 1/7/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Glyburide Healthy Volunteer Study
Glyburide Healthy Volunteer Study
Status: Enrolling
Updated:  1/7/2013
Washington University in St. Louis Clinical Research Unit (CRU)
mi
from
St. Louis, MO
Glyburide Healthy Volunteer Study
Glyburide Healthy Volunteer Study
Status: Enrolling
Updated: 1/7/2013
Washington University in St. Louis Clinical Research Unit (CRU)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
Status: Enrolling
Updated:  1/8/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
Status: Enrolling
Updated: 1/8/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects
Status: Enrolling
Updated:  1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects
Status: Enrolling
Updated: 1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Effects of Gastric pH on the Pharmacokinetics of Atazanavir
Effects of Gastric pH on the Pharmacokinetics of Atazanavir in Healthy Volunteers
Status: Enrolling
Updated:  1/9/2013
Clinical Research Center, UCSF
mi
from
San Francisco, CA
Effects of Gastric pH on the Pharmacokinetics of Atazanavir
Effects of Gastric pH on the Pharmacokinetics of Atazanavir in Healthy Volunteers
Status: Enrolling
Updated: 1/9/2013
Clinical Research Center, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of LY2157299 Monohydrate in Healthy Volunteers
Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated:  1/10/2013
Clinical Research Facility
mi
from
Burlington, WI
A Study of LY2157299 Monohydrate in Healthy Volunteers
Disposition of [14C]-LY2157299 Monohydrate Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated: 1/10/2013
Clinical Research Facility
mi
from
Burlington, WI
Click here to add this to my saved trials
Prenatal Education Video Study
Prenatal Education Video Study
Status: Enrolling
Updated:  1/13/2013
University of Virginia Health System
mi
from
Charlottesville, VA
Prenatal Education Video Study
Prenatal Education Video Study
Status: Enrolling
Updated: 1/13/2013
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Prenatal Education Video Study
Prenatal Education Video Study
Status: Enrolling
Updated:  1/13/2013
Virginia Commonwealth University
mi
from
Richmond, VA
Prenatal Education Video Study
Prenatal Education Video Study
Status: Enrolling
Updated: 1/13/2013
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers
An Open-Label Study to Assess the Effects of Repeated Twice-Daily Doses of Ketoconazole on the Steady-State Pharmacokinetics of JNJ-38518168 in Healthy Subjects
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Newark, NJ
Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers
An Open-Label Study to Assess the Effects of Repeated Twice-Daily Doses of Ketoconazole on the Steady-State Pharmacokinetics of JNJ-38518168 in Healthy Subjects
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia
Status: Enrolling
Updated:  1/18/2013
Boston University
mi
from
Boston, MA
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia
Status: Enrolling
Updated: 1/18/2013
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia
Status: Enrolling
Updated:  1/18/2013
Southern Methodist University
mi
from
Dallas, TX
Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
Placebo-Controlled Evaluation of the Efficacy of Yohimbine Hydrochloride for Enhancing the Effects of CBT for Social Phobia
Status: Enrolling
Updated: 1/18/2013
Southern Methodist University
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Oral Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of DSP-1053 in Healthy Subjects and in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  1/21/2013
California Clinical Trials Medical Group
mi
from
Glendale, CA
A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Oral Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of DSP-1053 in Healthy Subjects and in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 1/21/2013
California Clinical Trials Medical Group
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of LY2940680 in Healthy Participants
Disposition of [14C]-LY2940680 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated:  1/23/2013
Clinical Research Facility
mi
from
Burlington, WI
A Study of LY2940680 in Healthy Participants
Disposition of [14C]-LY2940680 Following Oral Administration in Healthy Subjects
Status: Enrolling
Updated: 1/23/2013
Clinical Research Facility
mi
from
Burlington, WI
Click here to add this to my saved trials
A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GI-13020 at Various Dose Levels and Regimens in Healthy Adults.
A Randomized, Open-Label, Multi-Arm, Dose Escalation, Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GI-13020; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Hepatitis B Virus X, Surface and Core Antigens, at Various Dose Levels and Regimens in Healthy Adults.
Status: Enrolling
Updated:  1/28/2013
Celerion
mi
from
Tempe, AZ
A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GI-13020 at Various Dose Levels and Regimens in Healthy Adults.
A Randomized, Open-Label, Multi-Arm, Dose Escalation, Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GI-13020; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Hepatitis B Virus X, Surface and Core Antigens, at Various Dose Levels and Regimens in Healthy Adults.
Status: Enrolling
Updated: 1/28/2013
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Impact of Formulation on Ciprofloxacin Oral Absorption
Impact of Formulation on Ciprofloxacin Oral Absorption
Status: Enrolling
Updated:  1/29/2013
University of Maryland
mi
from
Baltimore, MD
Impact of Formulation on Ciprofloxacin Oral Absorption
Impact of Formulation on Ciprofloxacin Oral Absorption
Status: Enrolling
Updated: 1/29/2013
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Changes in Bleeding and Clotting During the Menstrual Cycle
Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
Status: Enrolling
Updated:  2/6/2013
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Changes in Bleeding and Clotting During the Menstrual Cycle
Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
Status: Enrolling
Updated: 2/6/2013
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
Phase 1 Randomized, Double-Blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Repeat Administration (7 Days) of Ascending Oral Doses of Bendavia in Healthy Volunteers
Status: Enrolling
Updated:  2/6/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
Phase 1 Randomized, Double-Blind, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Repeat Administration (7 Days) of Ascending Oral Doses of Bendavia in Healthy Volunteers
Status: Enrolling
Updated: 2/6/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 Including an Open-Label Food Effect Group in Healthy Male and Non-Fertile Female Volunteers
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 Including an Open-Label Food Effect Group in Healthy Male and Non-Fertile Female Volunteers
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
ANX-188 Thorough QT/QTc Study in Healthy Volunteers
A Four Period, Four-Arm, Crossover Design, Randomized, Placebo and Active Controlled Study for the Evaluation of the Effect of Therapeutic and Supratherapeutic Single-Dose ANX-188 on the QT/QTc Intervals in Healthy Volunteers
Status: Enrolling
Updated:  2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
ANX-188 Thorough QT/QTc Study in Healthy Volunteers
A Four Period, Four-Arm, Crossover Design, Randomized, Placebo and Active Controlled Study for the Evaluation of the Effect of Therapeutic and Supratherapeutic Single-Dose ANX-188 on the QT/QTc Intervals in Healthy Volunteers
Status: Enrolling
Updated: 2/11/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo-Controlled, Single Dose Escalating Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-06291874 After Administration Under Fasted And Fed Conditions In Healthy Adult Subjects
Status: Enrolling
Updated:  2/15/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult Subjects
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo-Controlled, Single Dose Escalating Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-06291874 After Administration Under Fasted And Fed Conditions In Healthy Adult Subjects
Status: Enrolling
Updated: 2/15/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Status: Enrolling
Updated:  2/19/2013
University of Virginia
mi
from
Charlottesville, VA
Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Status: Enrolling
Updated: 2/19/2013
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects
A Phase I, Open Interaction Study Between Oral Doses of GLPG0634 (200 mg QD) and Single Oral Doses of Midazolam (2 mg) in Healthy Subjects
Status: Enrolling
Updated:  2/25/2013
Covance Clinical Research Unit
mi
from
Madison, WI
A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects
A Phase I, Open Interaction Study Between Oral Doses of GLPG0634 (200 mg QD) and Single Oral Doses of Midazolam (2 mg) in Healthy Subjects
Status: Enrolling
Updated: 2/25/2013
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps
Cancer Care Engineering of Colorectal Cancer - OMICs Pilot Study
Status: Enrolling
Updated:  3/6/2013
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps
Cancer Care Engineering of Colorectal Cancer - OMICs Pilot Study
Status: Enrolling
Updated: 3/6/2013
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C] Prucalopride Succinate Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated:  3/6/2013
Covance Global Clinical Research Unit Inc.
mi
from
Madison, WI
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C] Prucalopride Succinate Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 3/6/2013
Covance Global Clinical Research Unit Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Two Dosage Forms of LY2886721 in Healthy Participants
A Comparison Study of Capsule and Orally Disintegrating Tablet and to Determine the Effect of Food and Water on the Pharmacokinetics of LY2886721 in Healthy Subjects
Status: Enrolling
Updated:  3/7/2013
Clinical Research Facility
mi
from
Burlington, WI
A Study of Two Dosage Forms of LY2886721 in Healthy Participants
A Comparison Study of Capsule and Orally Disintegrating Tablet and to Determine the Effect of Food and Water on the Pharmacokinetics of LY2886721 in Healthy Subjects
Status: Enrolling
Updated: 3/7/2013
Clinical Research Facility
mi
from
Burlington, WI
Click here to add this to my saved trials
A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PD-0332991 In Healthy Male Volunteers
A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PD-0332991 In Healthy Male Volunteers
Status: Enrolling
Updated:  3/14/2013
Pfizer Investigational Site
mi
from
Seattle, WA
A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PD-0332991 In Healthy Male Volunteers
A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] PD-0332991 In Healthy Male Volunteers
Status: Enrolling
Updated: 3/14/2013
Pfizer Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
A Safety, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects and Patients Diagnosed With Alzheimer's Disease
Status: Enrolling
Updated:  3/14/2013
Clinical Research Facility
mi
from
American Fork, UT
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
A Safety, Pharmacokinetic, and Pharmacodynamic Study of LY2886721 in Healthy Subjects and Patients Diagnosed With Alzheimer's Disease
Status: Enrolling
Updated: 3/14/2013
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Status: Enrolling
Updated:  3/15/2013
Parexel
mi
from
Glendale, CA
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Status: Enrolling
Updated: 3/15/2013
Parexel
mi
from
Glendale, CA
Click here to add this to my saved trials
Effects of Gastric pH on the Pharmacokinetics of Dasatinib
Effects of Gastric pH on the Pharmacokinetics of Dasatinib in Healthy Volunteers
Status: Enrolling
Updated:  3/18/2013
Clinical Research Center, UCSF
mi
from
San Francisco, CA
Effects of Gastric pH on the Pharmacokinetics of Dasatinib
Effects of Gastric pH on the Pharmacokinetics of Dasatinib in Healthy Volunteers
Status: Enrolling
Updated: 3/18/2013
Clinical Research Center, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification
Status: Enrolling
Updated:  3/25/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification
Status: Enrolling
Updated: 3/25/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study To Assess Relative Boavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation
A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation Of Pf-05175157 And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation In Healthy Volunteers
Status: Enrolling
Updated:  3/26/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
A Study To Assess Relative Boavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation
A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation Of Pf-05175157 And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation In Healthy Volunteers
Status: Enrolling
Updated: 3/26/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Users Study Of The Caverject Delivery System
A Representative Users Study Of The Operating Characteristics Of The Caverject Delivery System
Status: Enrolling
Updated:  3/27/2013
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Users Study Of The Caverject Delivery System
A Representative Users Study Of The Operating Characteristics Of The Caverject Delivery System
Status: Enrolling
Updated: 3/27/2013
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety And Tolerability Study Of BID Titration Scheme With PF-05089771
An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-05089771 In Healthy Subjects
Status: Enrolling
Updated:  3/27/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Safety And Tolerability Study Of BID Titration Scheme With PF-05089771
An Investigator And Subject Blinded, Sponsor Open, Randomized, Placebo Controlled, Multiple Dose Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-05089771 In Healthy Subjects
Status: Enrolling
Updated: 3/27/2013
Pfizer Investigational Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]SSP-004184 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated:  4/1/2013
Covance Clinical Research Unit Inc
mi
from
Madison, WI
AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of [14C]SSP-004184 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 4/1/2013
Covance Clinical Research Unit Inc
mi
from
Madison, WI
Click here to add this to my saved trials
The Impact of Proton Pump Inhibitors on the Fecal Microbiome
The Impact of Proton Pump Inhibitors on the Fecal Microbiome and Their Relationship to Clostridium Difficile Infection
Status: Enrolling
Updated:  4/2/2013
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
The Impact of Proton Pump Inhibitors on the Fecal Microbiome
The Impact of Proton Pump Inhibitors on the Fecal Microbiome and Their Relationship to Clostridium Difficile Infection
Status: Enrolling
Updated: 4/2/2013
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials